Abaloparatide Subcutaneous and Didanosine Delayed-Release Enteric-Coated Capsules
Determining the interaction of Abaloparatide Subcutaneous and Didanosine Delayed-Release Enteric-Coated Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: abaloparatide
Brand name: Tymlos
Synonyms: Abaloparatide
Generic Name: didanosine
Brand name: Videx, Videx EC
Synonyms: Didanosine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Abaloparatide Subcutaneous-Didanosine Oral Solution
- Abaloparatide Subcutaneous-Didanosine Tablet, for suspension
- Abaloparatide Subcutaneous-Didrex
- Abaloparatide Subcutaneous-Didronel
- Abaloparatide Subcutaneous-Dienogest and estradiol
- Abaloparatide Subcutaneous-Diethylene Triamine Penta-Acetic Acid
- Didanosine Delayed-Release Enteric-Coated Capsules-Abatacept
- Didanosine Delayed-Release Enteric-Coated Capsules-Abatacept Auto-Injectors
- Didanosine Delayed-Release Enteric-Coated Capsules-Abatacept Infusion
- Didanosine Delayed-Release Enteric-Coated Capsules-Abatacept Intravenous
- Didanosine Delayed-Release Enteric-Coated Capsules-Abatacept Prefilled Syringes
- Didanosine Delayed-Release Enteric-Coated Capsules-Abatron